Literature DB >> 11254545

Potential mechanisms causing delayed effects of respiratory syncytial virus infection.

P J Openshaw1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11254545     DOI： 10.1164/ajrccm.163.supplement_1.2011111

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  11 in total

1.  Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.

Authors:  Fu-Shi Quan; Yonghwan Kim; Sujin Lee; Hong Yi; Sang-Moo Kang; Jadranka Bozja; Martin L Moore; Richard W Compans
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

Review 2.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

Review 3.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

4.  Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

5.  Challenges and opportunities in developing respiratory syncytial virus therapeutics.

Authors:  Eric A F Simões; John P DeVincenzo; Michael Boeckh; Louis Bont; James E Crowe; Paul Griffiths; Frederick G Hayden; Richard L Hodinka; Rosalind L Smyth; Keith Spencer; Steffen Thirstrup; Edward E Walsh; Richard J Whitley
Journal:  J Infect Dis       Date:  2015-03-15       Impact factor: 5.226

6.  Association between early viral LRTI and subsequent wheezing development, a meta-analysis and sensitivity analyses for studies comparable for confounding factors.

Authors:  Sebastien Kenmoe; Arnol Bowo-Ngandji; Cyprien Kengne-Nde; Jean Thierry Ebogo-Belobo; Donatien Serge Mbaga; Gadji Mahamat; Cynthia Paola Demeni Emoh; Richard Njouom
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

7.  Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.

Authors:  S Tourdot; S Mathie; T Hussell; L Edwards; H Wang; P J M Openshaw; J Schwarze; C M Lloyd
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

Review 8.  Potential therapeutic implications of new insights into respiratory syncytial virus disease.

Authors:  Peter J M Openshaw
Journal:  Respir Res       Date:  2002

9.  Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.

Authors:  Ah-Ra Kim; Dong-Hun Lee; Su-Hwa Lee; Ilaria Rubino; Hyo-Jick Choi; Fu-Shi Quan
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

10.  Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya.

Authors:  Patrick Kiio Munywoki; Eric O Ohuma; Mwanajuma Ngama; Evasius Bauni; J Anthony G Scott; D James Nokes
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.